Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplant

21 Oct 2013

Abstract excerpt

Today, more than 80% of patients with Hodgkin lymphoma (HL) can be cured with first-line treatment [1–3]. For patients with HL suffering from relapse or progression after first-line therapy, high d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to CNS Lymphoma Diagnosis and Treatment
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24138304
DOI: 10.3109/10428194.2013.854888

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplantPMID 24138304Read ↗

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplantSemantic proximity Read ↗

From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.Semantic proximity Read ↗

Risk and Outcome of Second primary malignancy in patients with classical Hodgkin lymphomaSemantic proximity Read ↗

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantationSemantic proximity Read ↗

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with LymphomaSemantic proximity Read ↗

Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in JapanSemantic proximity Read ↗

Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.Semantic proximity Read ↗

Hodgkin's disease in Asians: incidence patterns and risk factors in population-based dataSemantic proximity Read ↗

Non-Hodgkin lymphoma: diagnosis and treatment.Semantic proximity Read ↗

The number of tumor infiltrating T-cell subsets in lymph nodes from patients with Hodgkin lymphoma is associated with the outcome after first line ABVD therapy<sup/>.Semantic proximity Read ↗

Analysis by TeloView® Technology Predicts the Response of Hodgkin’s Lymphoma to first line ABVD TherapySemantic proximity Read ↗

Advances in biology, diagnostics, and treatment of Hodgkin's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.